Share on LinkedInShare on LinkedIn

ARTICLE · 28 FEBRUARY 2024

BARDA BioMaP-Consortium Up And Running

In a previous Update, we reported on the Biomedical Advanced Research and Development Authority's (BARDA)[1] plans to implement...

United StatesGovernment, Public Sector

In a previous Update, we reported on the Biomedical Advanced Research and Development Authority's (BARDA)1 plans to implement the new Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP-Consortium or Consortium), which was created to ensure the nation's preparedness in the face of a future pandemic or other biomedical threat. These plans are now underway, with the first BioMaP-Consortium General Membership Meeting scheduled to take place in Washington, D.C., on February 21, 2024.

The Consortium was established in September 2023 when BARDA awarded Advanced Technology International (ATI) an Other Transaction Authority (OTA) agreement allowing ATI to act as the Consortium management firm. Under the OTA, Consortium members will be eligible to compete for awards of individual Project Agreements under specified Key Domain Areas.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from